JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, L.
Right arrow Articles by Sonner, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, L.
Right arrow Articles by Sonner, J. M.
Related Collections
Right arrow Mechanisms
Right arrow Pharmacology

Anesth Analg 2007;105:393-396
© 2007 International Anesthesia Research Society
doi: 10.1213/01.ane.0000267336.37735.d7


ANESTHETIC PHARMACOLOGY

The Plasticizer Di(2-ethylhexyl) Phthalate Modulates {gamma}-Aminobutyric Acid Type A and Glycine Receptor Function

Liya Yang, PhD*, Pavle S. Milutinovic, MS*, Robert J. Brosnan, DVM, PhD{dagger}, Edmond I. Eger, II, MD*, and James M. Sonner, MD*

From the *Department of Anesthesia and Perioperative Care, University of California, San Francisco, California; and {dagger}The Department of Surgical and Radiological Sciences, University of California, School of Veterinary Medicine, Davis, California.

Address correspondence to Sonner, MD, Department of Anesthesia, Room S-455i, Box 0464, 513 Parnassus Ave., University of California, San Francisco, CA 94143-0464. Address e-mail to sonnerj{at}anesthesia.ucsf.edu.


    Abstract
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
INTRODUCTION: Intravenous (IV) fluid bags made of polyvinyl chloride (PVC) often contain the plasticizer di(2-ethylhexyl) phthalate (DEHP) to make the PVC flexible. Phthalate esters have been reported to inhibit neuronal nicotinic acetylcholine receptors, which are sensitive to many inhaled anesthetics. This raises the possibility that DEHP might modulate the function of other cys-loop receptors, such as {gamma}-amino butyric acid type A (GABAA) and glycine receptors, and that DEHP-plasticized PVC might interfere with electrophysiologic studies of anesthetic mechanisms on those receptors.

METHODS: {alpha}1ß2 GABAA and {alpha}1 glycine receptors were expressed in Xenopus laevis oocytes and studied using two-electrode voltage clamping. We then measured the effect of buffers from IV bags containing DEHP-plasticized PVC, and of buffers saturated with DEHP, on agonist-induced currents.

RESULTS: Agonist-induced currents from glycine receptors were enhanced by buffers from IV bags containing DEHP-plasticized PVC by 291.9% ± 84.5% (mean ± se) and from saturated solutions of DEHP by 70.8% ± 16.7%. Agonist-induced currents from {alpha}1ß2 GABAA receptors were inhibited by buffers from IV bags containing DEHP-plasticized PVC by 19.3% ± 3.2% and by 31.7% ± 7.0% from buffers saturated with DEHP.

CONCLUSIONS: The plasticizer DEHP modulates the function of both GABAA and glycine receptors. DEHP contamination can confound the results of electrophysiologic studies of anesthetic mechanisms on these receptors if DEHP-plasticized PVC is present in the experimental apparatus.


    Introduction
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Plasticizers are used to render plastics containing polyvinyl chloride (PVC) flexible. Di(2-ethylhexyl) phthalate (DEHP), the most common of these plasticizers, comprises as much as 30%–40% of the plastics it is used in (1). IV fluid bags, tubing, and catheters are often composed of DEHP-plasticized PVC. Because DEHP is not covalently bound to the PVC polymer, it can leach out of these products. This has raised concerns about toxicity, primarily the estrogen-like effects of DEHP on reproductive health (2,3) [although the relevance of some animal studies to human exposures has been questioned (4)], and the possible carcinogenicity of DEHP (5,6).

Phthalate esters inhibit the cytosolic free calcium concentration induced by neuronal nicotinic acetylcholine receptor (nAChR) agonists (7). This was of interest to us because nAChRs are sensitive to volatile anesthetics (8). IV bags and tubing composed of DEHP are often used to contain buffers and drugs applied in studies of the physiology of anesthetic-sensitive ion channels because these bags and tubing provide a gas-tight containment system that can drain under gravity. The use of such bags and tubing could confound studies of anesthetic mechanisms using nAChR and related ion channels, owing to the presence of phthalates in the perfusate. We accordingly studied the response of two anesthetic-sensitive ion channels [{gamma}-amino butyric acid type A (GABAA) and glycine receptors] from the same cys-loop superfamily of receptors as the nAChR to perfusates in IV bags containing DEHP plasticized PVC and to perfusates saturated with DEHP.


    METHODS
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
GABAA and glycine receptor clones were a gift of Professor R. A. Harris (University of Texas, Austin). With permission of the Institutional Animal Care and Use Committee of University of California, San Francisco, oocytes were harvested from female Xenopus laevis frogs. Stage V and VI oocytes were defolliculated by gentle rotation in 0.5 U/mL collagenase type 1 (Worthingtom Biochemical Corporation, Lakewood, NJ) for 1 h at room temperature. GABAA receptors comprised of human {alpha}1 and rat ß2 subunits, and homomeric human {alpha}1 glycine receptors were expressed by microinjection of Xenopus laevis oocytes with 0.25–1 ng cDNA subcloned into PCIS2 and PBK-CMV vectors, respectively. Oocytes were maintained at 18°C in modified Barth's solution (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 20 mM HEPES, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, with 5 mM sodium pyruvate, 50 µg/mL gentamycin, 50 U/mL penicillin, and 50 µg/mL streptomycin, filtered and adjusted to pH 7.4).

Two to 3 days after injection, two-electrode voltage clamping was performed on oocytes at room temperature (GeneClamp 500B; Molecular Devices, Axon Instruments, Foster City, CA). Two-electrode voltage clamp experiments were performed using frog Ringer's (FR) solution as perfusate (115 mM NaCl, 2.5 mM KCl, 1.8 mM CaCl2,10 mM HEPES, filtered and adjusted to pH 7.4). An automated perfusion system was used to deliver solutions (Automate ValveBank perfusion system, San Francisco, CA). Teflon tubing connected the reservoirs containing buffer with the automated perfusion system, and the automated perfusion system to the oocyte recording chamber. Recordings were obtained in a 250-µL recording chamber at flow rates of 2–3 mL/min. Signals were filtered using a four-pole low-pass Bessel filter set at a 50–100 Hz cutoff before sampling at 100–1000 Hz.

Oocytes were voltage clamped at –80 mV. Stable inward currents in response to agonist were verified by application of agonist for 20 s before and after test compounds were studied. Two experiments were performed on each receptor. In the first, the effect of compounds leaching from IV bags containing DEHP-plasticized PVC bags was tested by placing FR plus agonist (either 30 µM GABA or 75 µM glycine) in an empty 250-mL capacity IntraVia bag, which contains DEHP-plasticized PVC (Baxter Healthcare Corporation, Deerfield, IL). This perfusate was applied to oocytes for 20 s.

In the second study, oocytes were perfused with a saturated solution made of 0.4 µL/L DEHP (Sigma-Aldrich, St. Louis, MO) in FR. A liter of this solution has 0.8 micromoles of DEHP, a concentration which exceeds the solubility of DEHP in water of 2.9 µg/L, or 0.0074 µM (9). This saturated DEHP solution and agonist in FR were coapplied to oocytes for 20 s.

The effect of perfusates from DEHP plasticized PVC bags, or from perfusates made up with DEHP, was compared with solutions made in FR contained in glass syringes and plastic bottles, which did not contain DEHP plasticizer. Perfusates were used as rapidly as they were made up, that is, we did not allow perfusates placed in DEHP plasticized PVC bags to equilibrate for prolonged times.

Statistics: Data are reported as means ± se. Groups were compared using a Student's t-test. P < 0.05 was considered significant.


    RESULTS
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
FR solutions from IntraVia IV bags inhibited GABA-induced currents from {alpha}1ß2 GABAA receptors by 19.3% ± 3.2% (P < 0.001) (n = 8 oocytes). Perfusate from these bags enhanced glycine-induced currents in homomeric human {alpha}1 glycine receptors by 291.9% ± 84.5% (P = 0.014) (n = 4 oocytes). See Figure 1 for a summary of these effects, and Figure 2 for representative current tracings.


Figure 120
View larger version (11K):
[in this window]
[in a new window]

 
Figure 1. (A) Perfusate from an IV bag containing di(2-ethylhexyl) phthalate (DEHP)-plasticized polyvinyl chloride ("bag") and a saturated solution of DEHP ("DEHP") both inhibit {alpha}1ß2 {gamma}-aminobutyric acid type A receptor function. (B) Perfusate from a bag containing DEHP-plasticized polyvinylchloride markedly potentiates {alpha}1 glycine receptor function, with a smaller but significant potentiation by a saturated solution of DEHP.

 

Figure 220
View larger version (15K):
[in this window]
[in a new window]

 
Figure 2. Current tracings. (A) Di(2-ethylhexyl) phthalate (DEHP) coapplied with glycine enhances currents through the glycine receptors. (B) Glycine applied from a bag made from DEHP-plasticizer polyvinyl chloride enhances currents through the glycine receptor compared to glycine applied from a glass syringe. (C) (DEHP) coapplied with {gamma}-aminobutyric acid (GABA) reduces currents through {alpha}1ß2 GABA type A (GABAA) receptors. (D) GABA applied from a bag made from DEHP-plasticizer polyvinyl chloride reduces currents through the GABAA receptor compared to GABA applied from a glass syringe.

 

Perfusate saturated with DEHP inhibited GABA-induced currents from {alpha}1ß2 GABAA receptors by 31.7% ± 7.0% (P = 0.004) (n = 4 oocytes). Perfusate saturated with DEHP enhanced glycine-induced currents in human glycine {alpha}1 receptors by 70.8% ± 16.7% (P = 0.003) (n = 5 oocytes). See Figure 1 for a summary of these effects, and Figure 2 for representative current tracings.

Perfusate from the bag and the DEHP solution did not differ in potentiation of {alpha}1ß2 GABAA receptors (P = 0.09). However, perfusate from the bag and the DEHP solution significantly differed in potentiation of {alpha}1 glycine receptors (P = 0.023).


    DISCUSSION
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We found that buffer from an IV bag containing DEHP-plasticized PVC inhibited {alpha}1ß2 GABAA receptors as much as a saturated solution of DEHP. By contrast, buffer from IV bags containing DEHP had an enhancing effect on {alpha}1 glycine receptors, an effect that was greater than for a saturated solution of DEHP, suggesting that another water soluble compound besides DEHP is present in these bags.

These results imply that DEHP contamination can confound the results of studies of anesthetic mechanisms on a variety of ion channels. Inhaled anesthetics generally enhance the function of both GABAA and glycine receptors (10). The presence of DEHP would exaggerate the effect of any inhaled anesthetic given concurrently during studies of glycine receptors and decrease the effect during studies of GABAA receptors. Unexpectedly large or small currents should raise the suspicion of a contaminant such as DEHP. The identification of contamination by plasticizers can be accomplished by comparing these currents with those obtained from perfusates contained in reservoirs that do not contain DEHP (or other phthalate plasticizers, presumably) such as Teflon or glass.

How does DEHP modulate channel function? Possibly, DEHP is modulating channel function in a manner similar to volatile anesthetic compounds. Although anesthetics and alcohols would be expected to enhance, rather than reduce, currents through GABAA receptors, volatile anesthetics as large as DEHP have not been studied on this receptor. Possibly, they show an inhibition of receptor function, much as anesthetic alcohols show inhibition or enhancement of nACh receptors as a function of the size of the alcohol (11). If DEHP is acting via a mechanism similar to volatile anesthetics, then its octanol solubility should predict its anesthetic potency [the Meyer-Overton relation (10,12)]. Is DEHP sufficiently soluble in octanol to produce anesthetic-like effects? DEHP's water solubility Cwater is 7.4 x 10–9 M and its octanol water partition (Kow) coefficient is 4.3 x 107 (9). Thus, a saturated solution of DEHP would produce an octanol concentration (Coctanol) of CwaterKow = 320 mM. This is indeed sufficient to produce anesthetic effects, since typically, volatile anesthetics require only 25 to 50 mM concentrations in a bulk octanol to produce anesthesia. For example, isoflurane (with a minimum alveolar concentration (MAC) of approximately 1.15% and octanol/gas partition coefficient of 88.2) has a bulk octanol concentration at MAC of 45 mM. Desflurane (with a MAC of approximately 6% and octanol/gas partition coefficient of 17.9) has a bulk octanol concentration at MAC of 46 mM.

However, even if DEHP modulates ion channels in a manner similar to volatile anesthetics in experiments on expressed receptors, DEHP's effects on ion channels are probably not important to the conduct of clinical anesthesia. To see why, we will calculate how much perfusate is required to achieve an anesthetic concentration of DEHP in the membranes of a single oocyte under study, and then of cell membranes in humans. How much perfusate, saturated with DEHP, is required to achieve a bulk octanol concentration in the membrane of an oocyte of 50 mM, the concentration predicted from the Meyer-Overton relation at MAC? Assuming a radius of 1 mm for an oocyte and a thickness of 30 Å for the bilayer gives a volume for the bilayer of 3.77 x 10–11 L. Further, assuming DEHP is as soluble in cell membranes as it is in octanol, to achieve a bulk octanol concentration of 50 mM would require only 0.2 mL of perfusate saturated with DEHP.

By contrast, achieving these bulk octanol concentrations in the membranes of cells in a human would require the infusion of unrealistically large volumes of DEHP-containing solutions. A Xenopus oocyte that is 1 mm in radius has a volume of 4.2 x 10–3 cm3. Assuming human tissue has an average density of approximately 1 gm/cm3, a 70 kg human has a volume equal to 1.7 x 107 oocytes. If a human had the same amount of membrane as this many oocytes (an assumption that greatly under-estimates the total DEHP uptake possible since human cells are smaller than Xenopus oocytes), and in addition had no other lipids to absorb DEHP (also an under-estimate, since it assumes no adipose tissue) then to achieve a concentration of 50 mM DEHP in membranes would require 2700 L of aqueous solution saturated with DEHP. Even direct exposure to plastics rather than to IV solutions would not seem to produce exposures large enough to produce neurologic effects in animals, since delivery would be via aqueous extracellular fluids in contact with plastic, in which DEHP would be poorly soluble, even though biochemically measurable effects on processes in neurons have been reported (13).


    Footnotes
 
Accepted for publication April 2, 2007.

Supported in part by NIGMS R01 GM069379 (to JS) and T32 GM08440 (to RB).

Dr. Eger is a paid consultant to Baxter Healthcare Corp.

Reprints will not be available from the author.


    REFERENCES
 Top
 Abstract
 Introduction
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Jayakrishnan A, Lakshmi S. Immobile plasticizer in flexible PVC. Nature 1998;396:638[Medline]
  2. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 1993;101:378–84[Web of Science][Medline]
  3. Safe SH. Environmental and dietary estrogens and human health: is there a problem? Environ Health Perspect 1995;103:346–51[Web of Science][Medline]
  4. Kaiser J. Toxicology. Panel finds no proof that phthalates harm infant reproductive systems. Science 2005;310:422
  5. Kluwe WM, Haseman JK, Douglas JF, Huff JE. The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health 1982;10:797–815[Web of Science][Medline]
  6. Cattley RC, Conway JG, Popp JA. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cancer Lett 1987;38:15–22[Web of Science][Medline]
  7. Liu PS, Lin CM. Phthalates suppress the calcium signaling of nicotinic acetylcholine receptors in bovine adrenal chromaffin cells. Toxicol Appl Pharmacol 2002;183:92–8[Web of Science][Medline]
  8. Flood P, Role LW. Neuronal nicotinic acetylcholine receptor modulation by general anesthetics. Toxicol Lett 1998;100:149–53[Medline]
  9. Cousins I, Mackay D. Correlating the physical-chemical properties of phthalate esters using the ‘three solubility’ approach. Chemosphere 2000;41:1389–99[Medline]
  10. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, Mascia MP, Valenzuela CF, Hanson KK, Greenblatt EP, Harris RA, Harrison NL. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997;389:385–9[Medline]
  11. Borghese CM, Henderson LA, Bleck V, Trudell JR, Harris RA. Sites of excitatory and inhibitory actions of alcohols on neuronal alpha2 beta4 nicotinic acetylcholine receptors. J Pharmacol Exp Ther 2003;307:42–52[Abstract/Free Full Text]
  12. Taheri S, Halsey MJ, Liu J, Eger EI II, Koblin DD, Laster MJ. What solvent best represents the site of action of inhaled anesthetics in humans, rats, and dogs? Anesth Analg 1991;72: 627–34[Abstract/Free Full Text]
  13. Tully K, Kupfer D, Dopico AM, Treistman SN. A plasticizer released from IV drip chambers elevates calcium levels in neurosecretory terminals. Toxicol Appl Pharmacol 2000;168:183–8[Web of Science][Medline]



This article has been cited by other articles:


Home page
Anesth. Analg.Home page
Y. Weng, T. T. Hsu, J. Zhao, S. Nishimura, G. G. Fuller, and J. M. Sonner
Isovaleric, Methylmalonic, and Propionic Acid Decrease Anesthetic EC50 in Tadpoles, Modulate Glycine Receptor Function, and Interact with the Lipid 1,2-Dipalmitoyl-Sn-Glycero-3-Phosphocholine
Anesth. Analg., May 1, 2009; 108(5): 1538 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. J. Brosnan and T. L. Pham
Carbon dioxide negatively modulates N-methyl-D-aspartate receptors
Br. J. Anaesth., November 1, 2008; 101(5): 673 - 679.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Yang and J. M. Sonner
The Anesthetic-Like Effects of Diverse Compounds on Wild-Type and Mutant {gamma}-Aminobutyric Acid Type A and Glycine Receptors
Anesth. Analg., March 1, 2008; 106(3): 838 - 845.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, L.
Right arrow Articles by Sonner, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, L.
Right arrow Articles by Sonner, J. M.
Related Collections
Right arrow Mechanisms
Right arrow Pharmacology


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2007 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press